D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
NAGE holding history
Niagen Bioscience, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NAGE overviewAll 13F holders of NAGEFull Q2 2026 holdings
- Shares (Q2 2026)
- 99,938
- Value
- $318.8K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 99,938 | $318.8K | <0.1% | −177,443−64.0% | Reduced | Holders |
| Q1 2026 | 277,381 | $1.22M | <0.1% | −69,164−20.0% | Reduced | Holders |
| Q4 2025 | 346,545 | $2.20M | <0.1% | −199,638−36.6% | Reduced | Holders |
| Q3 2025 | 546,183 | $5.10M | <0.1% | −1,055,625−65.9% | Reduced | Holders |
| Q2 2025 | 1,601,808 | $23.1M | <0.1% | +318,018+24.8% | Added | Holders |
| Q1 2025 | 1,283,790 | $8.86M | <0.1% | +272,500+26.9% | Added | Holders |
| Q4 2024 | 1,011,290 | $5.36M | <0.1% | +957,665+1,785.9% | Added | Holders |
| Q3 2024 | 53,625 | $195.7K | <0.1% | +53,625 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −37,694−100.0% | Sold out | Holders |
| Q2 2023 | 37,694 | $59.2K | <0.1% | −58,319−60.7% | Reduced | Holders |
| Q1 2023 | 96,013 | $146.9K | <0.1% | −60,433−38.6% | Reduced | Holders |
| Q4 2022 | 156,446 | $262.8K | <0.1% | +63,914+69.1% | Added | Holders |
| Q3 2022 | 92,532 | $114.0K | <0.1% | +25,208+37.4% | Added | Holders |
| Q2 2022 | 67,324 | $112.0K | <0.1% | −18,171−21.3% | Reduced | Holders |
| Q1 2022 | 85,495 | $210.0K | <0.1% | +23,453+37.8% | Added | Holders |
| Q4 2021 | 62,042 | $232.0K | <0.1% | +15,226+32.5% | Added | Holders |
| Q3 2021 | 46,816 | $294.0K | <0.1% | −41,336−46.9% | Reduced | Holders |
| Q2 2021 | 88,152 | $869.0K | <0.1% | +88,152 | New | Holders |